{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:51:28Z","timestamp":1790265088781,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jaip.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T14:17:07Z","timestamp":1510841827000},"page":"944-954.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease"],"prefix":"10.1016","volume":"6","author":[{"given":"Robert S.","family":"Zeiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung N.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaowu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak B.","family":"Khatry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaldo","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniket A.","family":"Kawatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.10.004_bib1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.06.00124605","article-title":"Global burden of COPD: systematic review and meta-analysis","volume":"28","author":"Halbert","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.10.004_bib2","first-page":"1040","article-title":"The 2007 GOLD Guidelines: a comprehensive care framework","volume":"54","author":"Gold","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.jaip.2017.10.004_bib3","author":"National Committee of Quality Assurance"},{"key":"10.1016\/j.jaip.2017.10.004_bib4","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)"},{"key":"10.1016\/j.jaip.2017.10.004_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaip.2015.04.010","article-title":"Outpatient chronic obstructive pulmonary disease management: going for the GOLD","volume":"3","author":"Bellinger","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.10.004_bib6","doi-asserted-by":"crossref","first-page":"160061","DOI":"10.1183\/16000617.0061-2016","article-title":"Prediction models for exacerbations in patients with COPD","volume":"26","author":"Guerra","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2017.10.004_bib7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(17)30207-2","article-title":"Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort","volume":"5","author":"Han","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib9","doi-asserted-by":"crossref","first-page":"w14439","DOI":"10.4414\/smw.2017.14439","article-title":"Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial","volume":"147","author":"Engel","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jaip.2017.10.004_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1164\/rccm.201607-1330OC","article-title":"Biomarkers predictive of exacerbations in the SPIROMICS and COPDGene cohorts","volume":"195","author":"Keene","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1472-6963-11-43","article-title":"Identifying and characterizing COPD patients in US managed care: a retrospective, cross-sectional analysis of administrative claims data","volume":"11","author":"Mapel","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jaip.2017.10.004_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/COPD.S40437","article-title":"Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis","volume":"8","author":"Abudagga","year":"2013","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2017.10.004_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1472-6963-11-37","article-title":"The\u00a0validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease","volume":"11","author":"Cooke","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jaip.2017.10.004_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population Study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib17","author":"National Committee of Quality Assurance"},{"key":"10.1016\/j.jaip.2017.10.004_bib18","author":"National Committee of Quality Assurance"},{"key":"10.1016\/j.jaip.2017.10.004_bib19","first-page":"650","article-title":"How well do the HEDIS asthma inclusion criteria identify persistent asthma?","volume":"11","author":"Mosen","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2017.10.004_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/thx.2007.082636","article-title":"Counting, analysing and reporting exacerbations of COPD in randomised controlled trials","volume":"63","author":"Aaron","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2017.10.004_bib21","doi-asserted-by":"crossref","first-page":"46s","DOI":"10.1183\/09031936.03.00078002","article-title":"COPD exacerbations: definitions and classifications","volume":"41","author":"Burge","year":"2003","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaip.2017.10.004_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaip.2014.06.005","article-title":"High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma","volume":"2","author":"Zeiger","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.10.004_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","article-title":"Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease","volume":"186","author":"Divo","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.jaip.2017.10.004_bib25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaci.2006.01.053","article-title":"Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data","volume":"117","author":"Schatz","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.10.004_bib26","first-page":"897","article-title":"Step-up care improves impairment in uncontrolled asthma: an administrative data study","volume":"16","author":"Zeiger","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2017.10.004_bib27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib29","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.10.004_bib30","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/COPD.S100338","article-title":"Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD","volume":"11","author":"Negewo","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2017.10.004_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/resp.12475","article-title":"Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease","volume":"20","author":"Eltboli","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2017.10.004_bib32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","article-title":"Eosinophils in COPD exacerbations are associated with increased readmissions","volume":"151","author":"Couillard","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2017.10.004_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/resp.12724","article-title":"Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD","volume":"21","author":"Hasegawa","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2017.10.004_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.chest.2016.01.026","article-title":"Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD","volume":"150","author":"Bafadhel","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2017.10.004_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/thx.2004.032516","article-title":"Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease","volume":"60","author":"Brightling","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2017.10.004_bib36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.06.00072105","article-title":"Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment","volume":"27","author":"Leigh","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.10.004_bib37","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1183\/13993003.01370-2015","article-title":"Blood eosinophils as a marker of response to inhaled corticosteroids in COPD","volume":"47","author":"Barnes","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.10.004_bib38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib39","first-page":"23","article-title":"Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients","volume":"11","author":"Park","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2017.10.004_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/long-acting beta-2 agonist efficacy in COPD","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2017.10.004_bib41","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1164\/ajrccm.158.5.9804028","article-title":"Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis","volume":"158","author":"Pizzichini","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1183\/09031936.00062614","article-title":"Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis","volume":"44","author":"Bafadhel","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.10.004_bib43","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.10.004_bib44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-2600(14)70187-0","article-title":"Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"2","author":"Brightling","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib45","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","article-title":"Stability of blood eosinophils in COPD and controls and the impact of gender, age, smoking and baseline counts","volume":"195","author":"Oshagbemi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib46","doi-asserted-by":"crossref","first-page":"e000151","DOI":"10.1136\/bmjresp-2016-000151","article-title":"Effect of inhaled corticosteroids on blood eosinophil count in steroid-naive patients with COPD","volume":"3","author":"Kreindler","year":"2016","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jaip.2017.10.004_bib47","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaip.2016.07.015","article-title":"Blood eosinophil count and outcomes in severe uncontrolled asthma: a prospective study","volume":"5","author":"Zeiger","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.10.004_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1513\/AnnalsATS.201310-354OC","article-title":"Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma","volume":"11","author":"Katz","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2017.10.004_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.rmed.2016.08.006","article-title":"Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma","volume":"118","author":"Westerhof","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaip.2015.10.002","article-title":"Characteristics and outcomes of HEDIS-defined asthma patients with COPD diagnostic coding","volume":"4","author":"Zeiger","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.10.004_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaip.2014.10.009","article-title":"The association of blood eosinophil counts to future asthma exacerbations in children with persistent asthma","volume":"3","author":"Zeiger","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.10.004_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2014.04.011","article-title":"High blood eosinophil count is associated with more frequent asthma attacks in asthma patients","volume":"113","author":"Tran","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.10.004_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pupt.2016.05.002","article-title":"Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast","volume":"39","author":"Ciolkowski","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.10.004_bib55","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(16)30190-4","article-title":"Eosinophils in COPD: the Janus of phenotyping response to therapy?","volume":"4","author":"Bhatt","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib56","first-page":"1","article-title":"Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients","volume":"7","author":"Make","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2017.10.004_bib57","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/COPD.S62750","article-title":"Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns","volume":"9","author":"Price","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2017.10.004_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.rmed.2005.04.004","article-title":"Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice","volume":"100","author":"Hoogendoorn","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.10.004_bib59","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2147\/COPD.S116072","article-title":"Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD","volume":"11","author":"Kang","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2017.10.004_bib60","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/thoraxjnl-2012-202103","article-title":"The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease","volume":"67","author":"Steer","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2017.10.004_bib61","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2147\/COPD.S112110","article-title":"A\u00a0year in the life of German patients with COPD: the DACCORD observational study","volume":"11","author":"Buhl","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2017.10.004_bib62","doi-asserted-by":"crossref","first-page":"e95305","DOI":"10.1371\/journal.pone.0095305","article-title":"Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010","volume":"9","author":"Ford","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2017.10.004_bib63","doi-asserted-by":"crossref","unstructured":"Sehl J, O'Doherty J, O'Connor R, O'Sullivan B, O'Regan A. Adherence to COPD management guidelines in general practice? A review of the literature [published online ahead of print July 22, 2017]. Ir J Med Sci. https:\/\/doi.org\/10.1007\/s11845-017-1651-7.","DOI":"10.1007\/s11845-017-1651-7"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817307547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817307547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:14:12Z","timestamp":1761974052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817307547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2213219817307547"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.10.004","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}